Big Gain For Matinas BioPharma Holdings, Inc.
Mon, Jul 27, 2026 at 07:39 PM
Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT) jumped higher at $0.33, representing a gain of 37.5%. On Mon, Jul 27, 2026, MTNB:NYSEMKT hit a New 2-Week Intraday High of $0.43. The stock appeared on our News Catalysts scanner on Mon, Jul 13, 2026 at 04:37 PM in the 'MERGER' category. From Mon, Jul 13, 2026, the stock recorded 20.00% Up Days and 9.09% Green Days
The stock spiked on Mon, Jul 27, 2026 at $0.43 with a volume of 198M+.
About Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT)
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company engaged in identifying & developing safe and effective broad spectrum therapeutics for the treatment of serious and life-threatening infections.
Top 10 Gainers:
- T3 Defense Inc Com New (DFNS:NASDAQ), 201.15%
- Baiya International Group Inc. (BIYA:NASDAQ), 116.06%
- Entera Bio Ltd. (ENTX:NASDAQ), 91.22%
- LiveWire Group, Inc. (LVWR:NYSE), 66.44%
- Gossamer Bio, Inc. (GOSS:NASDAQ), 46.62%
- The9 Limited (NCTY:NASDAQ), 41.43%
- Forte Biosciences, Inc. (FBRX:NASDAQ), 39.65%
- Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT), 37.53%
- NIP Group Inc. (NIPG:NASDAQ), 28.26%
- Skycorp Solar Group Ltd (PN:NASDAQ), 27.07%